Shares of Boston Scientific fell by 8.52% to $34.79 at 20:05 UTC on Tuesday, on what proved to be an all-around rough trading session with the New York Stock Exchange sliding by 0.26% to $13946.
Boston Scientific closed at $38.03, below its 52-week high of $46.62.
Boston Scientific’s sales growth for the next quarter is 10.5%. The company’s growth estimates for the next quarter is 28.6%.
Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 10.11B for the twelve trailing months.
Boston Scientific’s stock is valued at $34.79, way below its 52 Week High of $46.62 and way above its 52 Week Low of $24.1.
Boston Scientific’s worth is under its 50 day moving average of $37.64 and its 200 day moving average of $37.66.